Albendazole

This classification denotes an antihelminthic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F4216019LN. European Medicines Agency schedules Albendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05295MIG. Albendazole generally arises in the molecular formula C12H15N3O2S. The term ALBENDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, no. 10 1976, list 16.) ALBENDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule albendazole under HS 29339990 and SITC 51577. As of Q4 2014, ALBENDAZOLE remains the US FDA Preferred Term for this commodity. Albendazole bears US NLM identifiers UMLS ID C0591462 and NCI Concept Code C47384. SMILES: CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC.